Coletta, D K <br/><br/>
Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial.  [electronic resource] 

 -  Diabetologia  Apr 2009 
 - 723-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1432-0428 
<br/><br/><label>Standard No.: </label>10.1007/s00125-008-1256-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--drug effects<br/>Adiponectin--blood<br/>Blood Glucose--drug effects<br/>DNA Primers<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Diet, Diabetic<br/>Double-Blind Method<br/>Fatty Acids, Nonesterified--blood<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Glucose Clamp Technique<br/>Humans<br/>Hyperinsulinism<br/>Hypoglycemic Agents--therapeutic use<br/>Male<br/>Malonyl Coenzyme A--metabolism<br/>Middle Aged<br/>Mitochondria, Muscle--metabolism<br/>Pioglitazone<br/>Polymerase Chain Reaction<br/>RNA, Messenger--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Thiazolidinediones--therapeutic use